{
    "Trade/Device Name(s)": [
        "ADVIA Chemistry Hemoglobin A1c Assay",
        "ADVIA Chemistry A1c Calibrators"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics",
    "510(k) Number": "k081895",
    "Predicate Device Reference 510(k) Number(s)": [
        "k011434",
        "k041764"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "JIX"
    ],
    "Summary Letter Date": "January 8, 2009",
    "Summary Letter Received Date": "November 19, 2008",
    "Submission Date": "November 18, 2008",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylate hemoglobin assay"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Lithium Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ADVIA Chemistry System",
        "ADVIA 1800"
    ],
    "Method(s)/Technology(ies)": [
        "Latex agglutination inhibition",
        "Alkaline hematin conversion"
    ],
    "Methodologies": [
        "Immunoassay",
        "Spectrophotometric measurement"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA Chemistry Hemoglobin A1c assay and calibrators for quantitation of HbA1c in whole blood on ADVIA Chemistry systems.",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on ADVIA Chemistry systems for monitoring long-term glycemic control; calibrators are for calibration of A1c and total hemoglobin methods on ADVIA Chemistry Systems.",
    "fda_folder": "Hematology"
}